Form 8-K - Current report:
SEC Accession No. 0001437749-20-021115
Filing Date
2020-10-14
Accepted
2020-10-14 06:04:54
Documents
3
Period of Report
2020-10-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vxrt20201013_8k.htm 8-K 59049
2 EXHIBIT 1.1 ex_206969.htm EX-1.1 256280
3 EXHIBIT 5.1 ex_206968.htm EX-5.1 8065
  Complete submission text file 0001437749-20-021115.txt   324951
Mailing Address 385 OYSTER POINT BOULEVARD, SUITE 9A SOUTH SAN FRANCISCO CA 94080
Business Address 385 OYSTER POINT BOULEVARD, SUITE 9A SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 201238171
SIC: 2836 Biological Products, (No Diagnostic Substances)